breast cancer research journal impact factor

Breast Cancer Research

Journal Abbreviation: BREAST CANCER RES Journal ISSN: 1465-542X

You may also be interested in the following journals

• ► Breast Cancer Research and Treatment
• ► PLoS One
• ► Cancer Research
• ► British Journal of Cancer
• ► Clinical Cancer Research
• ► Molecular Cancer Research
• ► Cancer Science
• ► Molecular Cancer
• ► Breast Cancer
• ► Science Translational Medicine

Top Journals in medicine

• New England Journal of Medicine
• Nature Reviews Drug Discovery
• Jama-Journal of The American Medical Association
• Nature Reviews Cancer
• Nature Reviews Immunology
• Lancet Oncology
• Nature Reviews Neuroscience
• Nature Medicine
• World Psychiatry
• Lancet Neurology
• Journal of Clinical Oncology

Journal Impact

Breast Cancer Research - Impact Score, Ranking, SJR, h-index, Citescore, Rating, Publisher, ISSN, and Other Important Details

Published By: BioMed Central Ltd.

Abbreviation: Breast Cancer Res.

Impact Score The impact Score or journal impact score (JIS) is equivalent to Impact Factor. The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science. On the other hand, Impact Score is based on Scopus data.

Important details.

About Breast Cancer Research

Breast Cancer Research is a journal published by BioMed Central Ltd. . This journal covers the area[s] related to Cancer Research, Oncology, etc . The coverage history of this journal is as follows: 1999-2022. The rank of this journal is 961 . This journal's impact score, h-index, and SJR are 6.91, 167, and 2.408, respectively. The ISSN of this journal is/are as follows: 1465542X, 14655411 . The best quartile of Breast Cancer Research is Q1 . This journal has received a total of 2987 citations during the last three years (Preceding 2022).

Breast Cancer Research Impact Score 2022-2023

The impact score (IS), also denoted as the Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Prediction of Breast Cancer Research Impact Score 2023

Impact Score 2022 of Breast Cancer Research is 6.91 . If a similar downward trend continues, IS may decrease in 2023 as well.

Impact Score Graph

Check below the impact score trends of breast cancer research. this is based on scopus data..

Breast Cancer Research h-index

The h-index of Breast Cancer Research is 167 . By definition of the h-index, this journal has at least 167 published articles with more than 167 citations.

What is h-index?

The h-index (also known as the Hirsch index or Hirsh index) is a scientometric parameter used to evaluate the scientific impact of the publications and journals. It is defined as the maximum value of h such that the given Journal has published at least h papers and each has at least h citations.

Breast Cancer Research ISSN

The International Standard Serial Number (ISSN) of Breast Cancer Research is/are as follows: 1465542X, 14655411 .

The ISSN is a unique 8-digit identifier for a specific publication like Magazine or Journal. The ISSN is used in the postal system and in the publishing world to identify the articles that are published in journals, magazines, newsletters, etc. This is the number assigned to your article by the publisher, and it is the one you will use to reference your article within the library catalogues.

ISSN code (also called as "ISSN structure" or "ISSN syntax") can be expressed as follows: NNNN-NNNC Here, N is in the set {0,1,2,3...,9}, a digit character, and C is in {0,1,2,3,...,9,X}

Breast Cancer Research Ranking and SCImago Journal Rank (SJR)

SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

Breast Cancer Research Publisher

The publisher of Breast Cancer Research is BioMed Central Ltd. . The publishing house of this journal is located in the United Kingdom . Its coverage history is as follows: 1999-2022 .

Call For Papers (CFPs)

Please check the official website of this journal to find out the complete details and Call For Papers (CFPs).

Abbreviation

The International Organization for Standardization 4 (ISO 4) abbreviation of Breast Cancer Research is Breast Cancer Res. . ISO 4 is an international standard which defines a uniform and consistent system for the abbreviation of serial publication titles, which are published regularly. The primary use of ISO 4 is to abbreviate or shorten the names of scientific journals using the technique of List of Title Word Abbreviations (LTWA).

As ISO 4 is an international standard, the abbreviation ('Breast Cancer Res.') can be used for citing, indexing, abstraction, and referencing purposes.

How to publish in Breast Cancer Research

If your area of research or discipline is related to Cancer Research, Oncology, etc. , please check the journal's official website to understand the complete publication process.

Acceptance Rate

• Interest/demand of researchers/scientists for publishing in a specific journal/conference.
• The complexity of the peer review process and timeline.
• Time taken from draft submission to final publication.
• Number of submissions received and acceptance slots
• And Many More.

The simplest way to find out the acceptance rate or rejection rate of a Journal/Conference is to check with the journal's/conference's editorial team through emails or through the official website.

Frequently Asked Questions (FAQ)

What is the impact score of breast cancer research.

The latest impact score of Breast Cancer Research is 6.91. It is computed in the year 2023.

What is the h-index of Breast Cancer Research?

The latest h-index of Breast Cancer Research is 167. It is evaluated in the year 2023.

What is the SCImago Journal Rank (SJR) of Breast Cancer Research?

The latest SCImago Journal Rank (SJR) of Breast Cancer Research is 2.408. It is calculated in the year 2023.

What is the ranking of Breast Cancer Research?

The latest ranking of Breast Cancer Research is 961. This ranking is among 27955 Journals, Conferences, and Book Series. It is computed in the year 2023.

Who is the publisher of Breast Cancer Research?

Breast Cancer Research is published by BioMed Central Ltd.. The publication country of this journal is United Kingdom.

What is the abbreviation of Breast Cancer Research?

This standard abbreviation of Breast Cancer Research is Breast Cancer Res..

Is "Breast Cancer Research" a Journal, Conference or Book Series?

Breast Cancer Research is a journal published by BioMed Central Ltd..

What is the scope of Breast Cancer Research?

• Cancer Research

For detailed scope of Breast Cancer Research, check the official website of this journal.

What is the ISSN of Breast Cancer Research?

The International Standard Serial Number (ISSN) of Breast Cancer Research is/are as follows: 1465542X, 14655411.

What is the best quartile for Breast Cancer Research?

The best quartile for Breast Cancer Research is Q1.

What is the coverage history of Breast Cancer Research?

The coverage history of Breast Cancer Research is as follows 1999-2022.

Credits and Sources

• Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
• Journal Impact Factor, https://clarivate.com/
• Issn.org, https://www.issn.org/
• Scopus, https://www.scopus.com/

Note: The impact score shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Impact Score, SJR, h-Index, and Other Important metrics of These Journals, Conferences, and Book Series

Check complete list

Breast Cancer Research Impact Score (IS) Trend

Top Journals/Conferences in Cancer Research

Top journals/conferences in oncology.

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

• View all journals
• Explore content
• About the journal
• Publish with us
• Sign up for alerts

Journal Metrics

Dora: the san francisco declaration on research assessment.

Springer Nature is a signatory of the San Francisco Declaration on Research Assessment (DORA). Because small numbers of highly cited articles can have outsized influence on certain citation measures like the 2-year Journal Impact Factor (JIF) (see below for definition), Springer Nature believes that these citation measures are not necessarily measures of journal quality, and that authors and readers should consider a range of metrics when evaluating journals to read and publish in.

Article metrics such as number of downloads, citations and online attention are available from each article page, and provide an overview of the attention received by a paper.

For recently launched journals, metrics are calculated from available citation data. If a metric uses multiple years of data, new journals may have partial metrics.

Citation Impact 2023

• Journal Impact Factor: 6.5
• 5-year Journal Impact Factor: 6.6
• Immediacy Index: 2.0
• Eigenfactor® Score: 0.00828
• Article Influence Score: 2.4
• Submission to first editorial decision (median days): 7
• Submission to acceptance (median days): 198
• Downloads: 830,811
• Altmetric mentions: 6,484

Definitions

The metric definitions below are shared by all Springer Nature journals.

Citation Impact

Journal impact factor.

The Journal Impact Factor is defined as all citations to the journal in the current JCR year to items published in the previous two years, divided by the total number of scholarly items (these comprise articles, reviews, and proceedings papers) published in the journal in the previous two years. Though not a strict mathematical average, the Journal Impact Factor provides a functional approximation of the mean citation rate per citable item. A Journal Impact Factor of 1.0 means that, on average, the articles published one or two years ago have been cited one time. A Journal Impact Factor of 2.5 means that, on average, the articles published one or two years ago have been cited two and a half times. The citing works may be articles published in the same journal. However, most citing works are from different journals, proceedings, or books indexed in Web of Science Core Collection. (Source: Clarivate Analytics )

5-year Journal Impact Factor

The 5-year journal Impact Factor, available from 2007 onward, is the average number of times articles from the journal published in the past five years have been cited in the JCR year. It is calculated by dividing the number of citations in the JCR year by the total number of articles published in the five previous years. (Source: Clarivate Analytics )

Immediacy Index

The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. The aggregate Immediacy Index indicates how quickly articles in a subject category are cited. The Immediacy Index is calculated by dividing the number of citations to articles published in a given year by the number of articles published in that year. Because it is a per-article average, the Immediacy Index tends to discount the advantage of large journals over small ones. However, frequently issued journals may have an advantage because an article published early in the year has a better chance of being cited than one published later in the year. Many publications that publish infrequently or late in the year have low Immediacy Indexes. For comparing journals specializing in cutting-edge research, the immediacy index can provide a useful perspective. (Source: Clarivate Analytics )

Eigenfactor® Score

The Eigenfactor Score calculation is based on the number of times articles from the journal published in the past five years have been cited in the JCR year, but it also considers which journals have contributed these citations so that highly cited journals will influence the network more than lesser cited journals. References from one article in a journal to another article from the same journal are removed, so that Eigenfactor Scores are not influenced by journal self-citation. (Source: Clarivate Analytics )

Article Influence Score

The Article Influence Score determines the average influence of a journal's articles over the first five years after publication. It is calculated by multiplying the Eigenfactor Score by 0.01 and dividing by the number of articles in the journal, normalized as a fraction of all articles in all publications. This measure is roughly analogous to the 5-Year Journal Impact Factor in that it is a ratio of a journal’s citation influence to the size of the journal’s article contribution over a period of five years. (Source: Clarivate Analytics )

Submission to first editorial decision

This measures the median time in days from when the journal receives a manuscript submission to when the submission is either sent out for peer review or rejected.

Submission to acceptance

This measures the median time in days from when the journal receives a manuscript submission to when the submission is accepted. This includes all peer review and can also include time in revision.

Downloads reflect the number of times full text or PDF versions of articles are accessed directly from the journal website and Springer Link. Downloads are defined as HTML, LookInside, PDF, and Epub clicks. Please note that this does not include article downloads from mirror databases such as PubMed Central. These download counts comply with the COUNTER5 standard. COUNTER5 is the fifth iteration of the “Code of Practice,” from Counter Metrics , which is a not-for-profit organization financially sustained by its global community of members, including libraries, consortia, publishers, aggregators, and technology providers.

Altmetric mentions

Total number of mentions (e.g. X, Facebook, Reddit, Blogs, News articles, Policy documents, and Faculty of 1000 reviews) for articles published in the specified timeframe, as provided by Altmetric .

Quick links

• Explore articles by subject
• Guide to authors
• Editorial policies

Breast Cancer

• Fosters progress in basic, translational, and clinical research.
• Develops a new focus and perspectives for all engaged in breast cancer studies.
• Publishes a variety of content, including original articles, case reports, and review articles.
• Committed to delivering up-to-date information on pivotal issues in breast cancer.
• Takayuki Ueno

Societies and partnerships

Latest issue

Volume 31, Issue 5

Latest articles

Clinicopathological and prognostic features of her2-null and her2-low advanced breast cancer treated with eribulin or capecitabine.

• Rui Kitadai
• Tatsunori Shimoi
• Kan Yonemori

Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community

• Mitsuhiro Watanabe
• Shinya Fujiki
• Takayuki Inomata

Trastuzumab deruxtecan for the treatment of patients with HER2-positive breast cancer with brain and/or leptomeningeal metastases: an updated overall survival analysis using data from a multicenter retrospective study (ROSET-BM)

• Takahiro Nakayama
• Naoki Niikura
• Junji Tsurutani

Targeted therapies in HER2-positive breast cancer with receptor-redirected Arazyme-linker-Herceptin as a novel fusion protein

• Farideh Rahmani
• Hatef Ajoudanifar
• Abbas Ali Imani Fooladi

Acute toxicity of hypofractionated radiotherapy for Japanese breast cancer patients after surgery: a single center prospective observational study (HyPORT-BC)

• Masaki Nakamura
• Takeshi Fujisawa
• Sadamoto Zenda

Journal updates

Best of breast cancer 2023.

2023 Best of Breast Cancer winners

The JBCS editorial committee has selected the following as the most influential articles from Breast Cancer

Journal information

• Current Contents/Clinical Medicine
• Google Scholar
• INIS Atomindex
• Japanese Science and Technology Agency (JST)
• Norwegian Register for Scientific Journals and Series
• OCLC WorldCat Discovery Service
• Science Citation Index Expanded (SCIE)
• Semantic Scholar
• TD Net Discovery Service
• UGC-CARE List (India)

Rights and permissions

Editorial policies

© The Japanese Breast Cancer Society

• Find a journal
• Publish with us
• Track your research

Breast Cancer Research and Treatment

Subject Area and Category

• Cancer Research

Springer New York

Publication type

01676806, 15737217

Information

How to publish in this journal

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

Evolution of the number of published documents. All types of documents are considered, including citable and non citable documents.

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years. Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

Evolution of the percentage of female authors.

Evolution of the number of documents cited by public policy documents according to Overton database.

Evoution of the number of documents related to Sustainable Development Goals defined by United Nations. Available from 2018 onwards.

Leave a comment

Name * Required

Email (will not be published) * Required

* Required Cancel

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Follow us on @ScimagoJR Scimago Lab , Copyright 2007-2024. Data Source: Scopus®

Cookie settings

Cookie Policy

Legal Notice

Privacy Policy

Information

• Author Services

Initiatives

You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess .

Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.

Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.

Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.

Original Submission Date Received: .

• Active Journals
• Find a Journal
• Proceedings Series
• For Authors
• For Reviewers
• For Editors
• For Librarians
• For Publishers
• For Societies
• For Conference Organizers
• Open Access Policy
• Institutional Open Access Program
• Special Issues Guidelines
• Editorial Process
• Research and Publication Ethics
• Article Processing Charges
• Testimonials
• Preprints.org
• SciProfiles
• Encyclopedia

Article Menu

• Subscribe SciFeed
• Recommended Articles
• Google Scholar
• on Google Scholar
• Table of Contents

Find support for a specific problem in the support section of our website.

Please let us know what you think of our products and services.

Visit our dedicated information section to learn more about MDPI.

JSmol Viewer

The effects of radiotherapy on the sequence and eligibility of breast reconstruction: current evidence and controversy.

Simple Summary

1. introduction, 2. breast reconstruction techniques, 2.1. overview of immediate reconstruction options, 2.2. overview of delayed reconstruction options, 3. influence of post-mastectomy radiotherapy on choice of reconstruction, 4. complications.

5. Influence of Post-Mastectomy Radiotherapy on Survival Outcomes

Impact of nodal and molecular subtypes on locoregional recurrence (lrr) and survival, 6. influence of post-mastectomy radiotherapy on cosmetic outcomes and patient satisfaction, 7. future directions and premrt, 8. conclusions, author contributions, conflicts of interest.

• Veronesi, P.; Ballardini, B.; De Lorenzi, F.; Magnoni, F.; Lissidini, G.; Caldarella, P.; Galimberti, V. Immediate breast reconstruction after mastectomy. Breast 2011 , 20 (Suppl. S3), S104–S107. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Galimberti, V.; Vicini, E.; Corso, G.; Morigi, C.; Fontana, S.; Sacchini, V.; Veronesi, P. Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications. Breast 2017 , 34 (Suppl. S1), S82–S84. [ Google Scholar ] [ CrossRef ]
• Scardina, L.; Di Leone, A.; Biondi, E.; Carnassale, B.; Sanchez, A.M.; D’Archi, S.; Franco, A.; Moschella, F.; Magno, S.; Terribile, D.; et al. Prepectoral vs. Submuscular Immediate Breast Reconstruction in Patients Undergoing Mastectomy after Neoadjuvant Chemotherapy: Our Early Experience. J. Pers. Med. 2022 , 12 , 1533. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Du, F.; Liu, R.; Zhang, H.; Xiao, Y.; Long, X. Post-mastectomy adjuvant radiotherapy for direct-to-implant and two-stage implant-based breast reconstruction: A meta-analysis. J. Plast. Reconstr. Aesthet. Surg. 2022 , 75 , 3030–3040. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Schmauss, D.; Machens, H.G.; Harder, Y. Breast Reconstruction after Mastectomy. Front. Surg. 2015 , 2 , 71. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Teymouri, H.; Stergioula, S.; Eder, M.; Kovacs, L.; Biemer, E.; Papadopulos, N. Breast reconstruction with autologous tissue following mastectomy. Hippokratia 2006 , 10 , 153–162. [ Google Scholar ]
• Rusby, J.E.; Waters, R.A.; Nightingale, P.G.; England, D.W. Immediate breast reconstruction after mastectomy: What are the long-term prospects? Ann. R. Coll. Surg. Engl. 2010 , 92 , 193–197. [ Google Scholar ] [ CrossRef ]
• Alderman, A.K.; Wilkins, E.G.; Kim, H.M.; Lowery, J.C. Complications in postmastectomy breast reconstruction: Two-year results of the Michigan Breast Reconstruction Outcome Study. Plast. Reconstr. Surg. 2002 , 109 , 2265–2274. [ Google Scholar ] [ CrossRef ]
• Von Glinski, M.; Holler, N.; Kummel, S.; Reinisch, M.; Wallner, C.; Wagner, J.M.; Dadras, M.; Sogorski, A.; Lehnhardt, M.; Behr, B. Autologous vs. implant-based breast reconstruction after skin- and nipple-sparing mastectomy-A deeper insight considering surgical and patient-reported outcomes. Front. Surg. 2022 , 9 , 903734. [ Google Scholar ] [ CrossRef ]
• Kronowitz, S.J.; Hunt, K.K.; Kuerer, H.M.; Babiera, G.; McNeese, M.D.; Buchholz, T.A.; Strom, E.A.; Robb, G.L. Delayed-immediate breast reconstruction. Plast. Reconstr. Surg. 2004 , 113 , 1617–1628. [ Google Scholar ] [ CrossRef ]
• Terao, Y.; Taniguchi, K.; Fujii, M.; Moriyama, S. Postmastectomy radiation therapy and breast reconstruction with autologous tissue. Breast Cancer 2017 , 24 , 505–510. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Shumway, D.A.; Momoh, A.O.; Sabel, M.S.; Jagsi, R. Integration of Breast Reconstruction and Postmastectomy Radiotherapy. J. Clin. Oncol. 2020 , 38 , 2329–2340. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Cordeiro, P.G.; Albornoz, C.R.; McCormick, B.; Hudis, C.A.; Hu, Q.; Heerdt, A.; Matros, E. What Is the Optimum Timing of Postmastectomy Radiotherapy in Two-Stage Prosthetic Reconstruction: Radiation to the Tissue Expander or Permanent Implant? Plast. Reconstr. Surg. 2015 , 135 , 1509–1517. [ Google Scholar ] [ CrossRef ]
• Baschnagel, A.M.; Shah, C.; Wilkinson, J.B.; Dekhne, N.; Arthur, D.W.; Vicini, F.A. Failure rate and cosmesis of immediate tissue expander/implant breast reconstruction after postmastectomy irradiation. Clin. Breast Cancer 2012 , 12 , 428–432. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Motwani, S.B.; Strom, E.A.; Schechter, N.R.; Butler, C.E.; Lee, G.K.; Langstein, H.N.; Kronowitz, S.J.; Meric-Bernstam, F.; Ibrahim, N.K.; Buchholz, T.A. The impact of immediate breast reconstruction on the technical delivery of postmastectomy radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2006 , 66 , 76–82. [ Google Scholar ] [ CrossRef ]
• Heine, N.; Eigenberger, A.; Brebant, V.; Kempa, S.; Seitz, S.; Prantl, L.; Kuehlmann, B. The effect of radiotherapy on fat engraftment for complete breast reconstruction using lipofilling only. Arch Gynecol. Obstet. 2023 , 307 , 549–555. [ Google Scholar ] [ CrossRef ]
• Debald, M.; Pech, T.; Kaiser, C.; Keyver-Paik, M.D.; Walgenbach-Bruenagel, G.; Kalff, J.C.; Kuhn, W.; Walgenbach, K.J. Lipofilling effects after breast cancer surgery in post-radiation patients: An analysis of results and algorithm proposal. Eur. J. Plast. Surg. 2017 , 40 , 447–454. [ Google Scholar ] [ CrossRef ]
• Tran, N.V.; Evans, G.R.; Kroll, S.S.; Baldwin, B.J.; Miller, M.J.; Reece, G.P.; Robb, G.L. Postoperative adjuvant irradiation: Effects on tranverse rectus abdominis muscle flap breast reconstruction. Plast. Reconstr. Surg. 2000 , 106 , 313–317; discussion 318–320. [ Google Scholar ] [ CrossRef ]
• Billig, J.; Jagsi, R.; Qi, J.; Hamill, J.B.; Kim, H.M.; Pusic, A.L.; Buchel, E.; Wilkins, E.G.; Momoh, A.O. Should Immediate Autologous Breast Reconstruction Be Considered in Women Who Require Postmastectomy Radiation Therapy? A Prospective Analysis of Outcomes. Plast. Reconstr. Surg. 2017 , 139 , 1279–1288. [ Google Scholar ] [ CrossRef ]
• Albino, F.P.; Koltz, P.F.; Ling, M.N.; Langstein, H.N. Irradiated autologous breast reconstructions: Effects of patient factors and treatment variables. Plast. Reconstr. Surg. 2010 , 126 , 12–16. [ Google Scholar ] [ CrossRef ]
• Dewael, S.; Vandevoort, M.; Fabre, G.; Nanhekhan, L. Immediate versus delayed autologous breast reconstruction: A retrospective matched cohort study of irradiated patients. J. Plast. Reconstr. Aesthet. Surg. 2019 , 72 , 1769–1775. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Jhaveri, J.D.; Rush, S.C.; Kostroff, K.; Derisi, D.; Farber, L.A.; Maurer, V.E.; Bosworth, J.L. Clinical outcomes of postmastectomy radiation therapy after immediate breast reconstruction. Int. J. Radiat. Oncol. Biol. Phys. 2008 , 72 , 859–865. [ Google Scholar ] [ CrossRef ]
• Maalouf, C.; Bou-Merhi, J.; Karam, E.; Patocskai, E.; Danino, A.M. The impact of autologous breast reconstruction using DIEP flap on the oncologic efficacy of radiation therapy. Ann. Chir. Plast. Esthet. 2017 , 62 , 630–636. [ Google Scholar ] [ CrossRef ]
• McCarthy, C.M.; Pusic, A.L.; Disa, J.J.; McCormick, B.L.; Montgomery, L.L.; Cordeiro, P.G. Unilateral postoperative chest wall radiotherapy in bilateral tissue expander/implant reconstruction patients: A prospective outcomes analysis. Plast. Reconstr. Surg. 2005 , 116 , 1642–1647. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Cordeiro, P.G.; Pusic, A.L.; Disa, J.J.; McCormick, B.; VanZee, K. Irradiation after immediate tissue expander/implant breast reconstruction: Outcomes, complications, aesthetic results, and satisfaction among 156 patients. Plast. Reconstr. Surg. 2004 , 113 , 877–881. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Rella, L.; Telegrafo, M.; Nardone, A.; Milella, A.; Ianora, A.A.S.; Lioce, M.; Angelelli, G.; Moschetta, M. MRI evaluation of post-mastectomy irradiated breast implants: Prevalence and analysis of complications. Clin. Radiol. 2015 , 70 , 948–953. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Benediktsson, K.; Perbeck, L. Capsular contracture around saline-filled and textured subcutaneously-placed implants in irradiated and non-irradiated breast cancer patients: Five years of monitoring of a prospective trial. J. Plast. Reconstr. Aesthet. Surg. 2006 , 59 , 27–34. [ Google Scholar ] [ CrossRef ]
• Ogita, M.; Nagura, N.; Kawamori, J.; In, R.; Yoshida, A.; Yamauchi, H.; Takei, J.; Hayashi, N.; Iwahira, Y.; Ohde, S.; et al. Risk factors for complications among breast cancer patients treated with post-mastectomy radiotherapy and immediate tissue-expander/permanent implant reconstruction: A retrospective cohort study. Breast Cancer 2018 , 25 , 167–175. [ Google Scholar ] [ CrossRef ]
• Fan, S.; Chen, H.; Grant, A.; DeLyzer, T. Outcomes of Immediate Alloplastic Breast Reconstruction in Patients Receiving Post-Mastectomy Radiotherapy. Plast. Surg. 2022 , 30 , 136–143. [ Google Scholar ] [ CrossRef ]
• Wu Young, M.Y.; Garza, R.M.; Chang, D.W. Immediate versus delayed autologous breast reconstruction in patients undergoing post-mastectomy radiation therapy: A paradigm shift. J. Surg. Oncol. 2022 , 126 , 949–955. [ Google Scholar ] [ CrossRef ]
• Matar, D.Y.; Wu, M.; Haug, V.; Orgill, D.P.; Panayi, A.C. Surgical complications in immediate and delayed breast reconstruction: A systematic review and meta-analysis. J. Plast. Reconstr. Aesthet. Surg. 2022 , 75 , 4085–4095. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Hershenhouse, K.S.; Bick, K.; Shauly, O.; Kondra, K.; Ye, J.; Gould, D.J.; Patel, K.M. Systematic review and meta-analysis of immediate versus delayed autologous breast reconstruction in the setting of post-mastectomy adjuvant radiation therapy. J. Plast. Reconstr. Aesthet. Surg. 2021 , 74 , 931–944. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• O’Donnell, J.P.M.; Murphy, D.; Ryan, E.J.; Gasior, S.A.; Sugrue, R.; O’Neill, B.L.; Boland, M.R.; Lowery, A.J.; Kerin, M.J.; McInerney, N.M. Optimal reconstructive strategies in the setting of post-mastectomy radiotherapy—A systematic review and network meta-analysis. Eur. J. Surg. Oncol. 2021 , 47 , 2797–2806. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Magill, L.J.; Robertson, F.P.; Jell, G.; Mosahebi, A.; Keshtgar, M. Determining the outcomes of post-mastectomy radiation therapy delivered to the definitive implant in patients undergoing one- and two-stage implant-based breast reconstruction: A systematic review and meta-analysis. J. Plast. Reconstr. Aesthet. Surg. 2017 , 70 , 1329–1335. [ Google Scholar ] [ CrossRef ]
• Overgaard, M.; Hansen, P.S.; Overgaard, J.; Rose, C.; Andersson, M.; Bach, F.; Kjaer, M.; Gadeberg, C.C.; Mouridsen, H.T.; Jensen, M.B.; et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N. Engl. J. Med. 1997 , 337 , 949–955. [ Google Scholar ] [ CrossRef ]
• Overgaard, M.; Jensen, M.B.; Overgaard, J.; Hansen, P.S.; Rose, C.; Andersson, M.; Kamby, C.; Kjaer, M.; Gadeberg, C.C.; Rasmussen, B.B.; et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999 , 353 , 1641–1648. [ Google Scholar ] [ CrossRef ]
• Kayali, M.; Abi Jaoude, J.; Mohammed, M.; Khabsa, J.; Tfayli, A.; Poortmans, P.; Zeidan, Y.H. Post-mastectomy Radiation Therapy in Triple-Negative Breast Cancer Patients: Analysis of the BEATRICE Trial. Ann. Surg. Oncol. 2022 , 29 , 460–466. [ Google Scholar ] [ CrossRef ]
• Abi Jaoude, J.; de Azambuja, E.; Makki, M.; Tamim, H.; Tfayli, A.; Geara, F.; Piccart, M.; Poortmans, P.; Zeidan, Y.H. Post-Mastectomy Radiation Therapy in Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Patients: Analysis of the HERA Trial. Int. J. Radiat. Oncol. Biol. Phys. 2020 , 106 , 503–510. [ Google Scholar ] [ CrossRef ]
• Libson, S.; Perez, E.; Takita, C.; Avisar, E. Post Mastectomy Radiation for Stage II Breast Cancer Patients with T1/T2 Lesions. Eur. J. Breast Health 2019 , 15 , 71–75. [ Google Scholar ] [ CrossRef ]
• Zhang, J.Q.; Lu, C.Y.; Qin, L.; Chen, H.M.; Wu, S.Y. Outcome of post-mastectomy radiotherapy after primary systemic treatment in patients with different clinical tumor and nodal stages of breast cancer: A cohort study. Am. J. Cancer Res. 2020 , 10 , 2185–2198. [ Google Scholar ]
• Scheer, A.S.; Zih, F.S.; Maki, E.; Koch, C.A.; McCready, D.R. Post-mastectomy Radiation: Should Subtype Factor into the Decision? Ann. Surg. Oncol. 2016 , 23 , 2462–2470. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Kyndi, M.; Sorensen, F.B.; Knudsen, H.; Overgaard, M.; Nielsen, H.M.; Overgaard, J.; Danish Breast Cancer Cooperative Group. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J. Clin. Oncol. 2008 , 26 , 1419–1426. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Wu, S.P.; Tam, M.; Shaikh, F.; Lee, A.; Chun, J.; Schnabel, F.; Guth, A.; Adams, S.; Schreiber, D.; Oh, C.; et al. Post-mastectomy Radiation Therapy in Breast Cancer Patients with Nodal Micrometastases. Ann. Surg. Oncol. 2018 , 25 , 2620–2631. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Pusic, A.L.; Klassen, A.F.; Scott, A.M.; Klok, J.A.; Cordeiro, P.G.; Cano, S.J. Development of a new patient-reported outcome measure for breast surgery: The BREAST-Q. Plast. Reconstr. Surg. 2009 , 124 , 345–353. [ Google Scholar ] [ CrossRef ]
• Kuhlefelt, C.; Repo, J.P.; Jahkola, T.; Kauhanen, S.; Homsy, P. Immediate versus delayed breast reconstruction: Long-term follow-up on health-related quality of life and satisfaction with breasts. J. Plast. Reconstr. Aesthet. Surg. 2024 , 88 , 478–486. [ Google Scholar ] [ CrossRef ]
• Pacaric, S.; Orkic, Z.; Babic, M.; Farcic, N.; Milostic-Srb, A.; Lovric, R.; Barac, I.; Miksic, S.; Vujanic, J.; Turk, T.; et al. Impact of Immediate and Delayed Breast Reconstruction on Quality of Life of Breast Cancer Patients. Int. J. Environ. Res. Public Health 2022 , 19 , 8546. [ Google Scholar ] [ CrossRef ]
• Yun, J.H.; Diaz, R.; Orman, A.G. Breast Reconstruction and Radiation Therapy. Cancer Control 2018 , 25 , 1073274818795489. [ Google Scholar ] [ CrossRef ]
• Kim, S.H.; Kim, J.M.; Park, S.H.; Lee, S.Y. Analysis of the effects of breast reconstruction in breast cancer patients receiving radiotherapy after mastectomy. Arch. Plast. Surg. 2012 , 39 , 222–226. [ Google Scholar ] [ CrossRef ]
• Reinders, F.C.J.; Young-Afat, D.A.; Batenburg, M.C.T.; Bruekers, S.E.; van Amerongen, E.A.; Macare van Maurik, J.F.M.; Braakenburg, A.; Zonnevylle, E.; Hoefkens, M.; Teunis, T.; et al. Higher reconstruction failure and less patient-reported satisfaction after post mastectomy radiotherapy with immediate implant-based breast reconstruction compared to immediate autologous breast reconstruction. Breast Cancer 2020 , 27 , 435–444. [ Google Scholar ] [ CrossRef ]
• Giunta, S.; Laidsaar-Powell, R.; Huang, L.; Hatcher, N.; Dhillon, H.; Muscat, D.M.; Carroll, S.; McNeil, C.; Burke, L.; Howson, P.; et al. Considering the type and timing of breast reconstruction after mastectomy: Qualitative insights into women’s decision-making. Eur. J. Oncol. Nurs. 2021 , 54 , 102024. [ Google Scholar ] [ CrossRef ]
• Flitcroft, K.; Brennan, M.; Spillane, A. Making decisions about breast reconstruction: A systematic review of patient-reported factors influencing choice. Qual. Life Res. 2017 , 26 , 2287–2319. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Holland, F.; Archer, S.; Montague, J. Younger women’s experiences of deciding against delayed breast reconstruction post-mastectomy following breast cancer: An interpretative phenomenological analysis. J. Health Psychol. 2016 , 21 , 1688–1699. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Schaverien, M.V.; Singh, P.; Smith, B.D.; Qiao, W.; Akay, C.L.; Bloom, E.S.; Chavez-MacGregor, M.; Chu, C.K.; Clemens, M.W.; Colen, J.S.; et al. Premastectomy Radiotherapy and Immediate Breast Reconstruction: A Randomized Clinical Trial. JAMA Netw. Open 2024 , 7 , e245217. [ Google Scholar ] [ CrossRef ] [ PubMed ]
• Facer, B.D.; Wang, T.; Weed, C.; Pariser, A.; Cherian, M.; Johnson, K.C.; Quiroga, D.; Stover, D.; Obeng-Gyasi, S.; Agnese, D.; et al. Radiation Management for Breast Cancer after Neoadjuvant Therapy. Curr. Breast Cancer Rep. 2023 , 15 , 371–378. [ Google Scholar ] [ CrossRef ]
• Sivina, E.; Blumberga, L.; Purkalne, G.; Irmejs, A. Pathological complete response to neoadjuvant chemotherapy in triple negative breast cancer—Single hospital experience. Hered. Cancer Clin. Pract. 2023 , 21 , 4. [ Google Scholar ] [ CrossRef ] [ PubMed ]

Click here to enlarge figure

Share and Cite

Campbell, A.R.; Didier, A.J.; Sheikh, T.M.; Ansari, S.; Watkins, D.E.; Fahoury, A.M.; Nandwani, S.V.; Rashid, M. The Effects of Radiotherapy on the Sequence and Eligibility of Breast Reconstruction: Current Evidence and Controversy. Cancers 2024 , 16 , 2939. https://doi.org/10.3390/cancers16172939

Campbell AR, Didier AJ, Sheikh TM, Ansari S, Watkins DE, Fahoury AM, Nandwani SV, Rashid M. The Effects of Radiotherapy on the Sequence and Eligibility of Breast Reconstruction: Current Evidence and Controversy. Cancers . 2024; 16(17):2939. https://doi.org/10.3390/cancers16172939

Campbell, Andrew R., Alexander J. Didier, Taha M. Sheikh, Sami Ansari, Dean E. Watkins, Alan M. Fahoury, Swamroop V. Nandwani, and Mohammad Rashid. 2024. "The Effects of Radiotherapy on the Sequence and Eligibility of Breast Reconstruction: Current Evidence and Controversy" Cancers 16, no. 17: 2939. https://doi.org/10.3390/cancers16172939

Article Metrics

Article access statistics, further information, mdpi initiatives, follow mdpi.

Subscribe to receive issue release notifications and newsletters from MDPI journals

Fees and funding

Article processing charges (apc).

Authors who publish open access in Breast Cancer Research are required to pay an article processing charge (APC). The APC price will be determined from the date on which the article is accepted for publication.

The current APC, subject to VAT or local taxes where applicable, is: £2890.00/$3990.00/€3290.00

Visit our open access support portal and our Journal Pricing FAQs for further information.

Open access funding

Visit Springer Nature’s open access funding & support services for information about research funders and institutions that provide funding for APCs.

Springer Nature offers agreements that enable institutions to cover open access publishing costs. Learn more about our open access agreements to check your eligibility and discover whether this journal is included.

Springer Nature offers APC waivers and discounts for articles published in our fully open access journals whose corresponding authors are based in the world’s lowest income countries (see our APC waivers and discounts policy for further information). Requests for APC waivers and discounts from other authors will be considered on a case-by-case basis, and may be granted in cases of financial need (see our open access policies for journals for more information). All applications for discretionary APC waivers and discounts should be made at the point of manuscript submission; requests made during the review process or after acceptance are unable to be considered.

• Editorial Board
• Manuscript editing services
• Instructions for Editors
• Sign up for article alerts and news from this journal
• Collections
• Follow us on Twitter

Annual Journal Metrics

Citation Impact 2023 Journal Impact Factor: 6.1 5-year Journal Impact Factor: 7.1 Source Normalized Impact per Paper (SNIP): 1.865 SCImago Journal Rank (SJR): 2.578 Speed 2023 Submission to first editorial decision (median days): 14 Submission to acceptance (median days): 129 Usage 2023 Downloads: 2,432,781 Altmetric mentions: 1,561

• More about our metrics

Breast Cancer Research

ISSN: 1465-542X

• Submission enquiries: [email protected]